Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2018

Pharma News, 2018

U.S.-Cuban biotech venture created to bring new cancer therapies to USA
U.S.-Cuban biotech venture created to bring new cancer therapies to USA
HAVANA (Reuters) - U.
Alexion To Acquire Syntimmune
Alexion To Acquire Syntimmune
BOSTON--(BUSINESS WIRE)--Sep.
Takeda’s Alunbrig shows promise as first-line ALK NSCLC therapy
Takeda’s Alunbrig shows promise as first-line ALK NSCLC therapy
Takeda’s Alunbrig cut the risk of disease progression or death by more than 50% compared to Pfizer’s Xalkori in adults with ALK+ non-small cell lung cancer.
Malaria 'breakthrough': Disease-carrying mosquitoes wiped out in major lab experiment
Malaria 'breakthrough': Disease-carrying mosquitoes wiped out in major lab experiment
Scientists in the U.
GSK vaccine success a milestone in TB, but room for improvement
GSK vaccine success a milestone in TB, but room for improvement
LONDON (Reuters) - An experimental GlaxoSmithKline vaccine could prevent tuberculosis developing in half of those who receive it, making it potentially the first new shot against the global ki...
FDA is considering banning online sales of e-cigarettes: Gottlieb
FDA is considering banning online sales of e-cigarettes: Gottlieb
Washington D.
Novartis to cut 2,550 jobs in Switzerland, UK in profit push
Novartis to cut 2,550 jobs in Switzerland, UK in profit push
ZURICH (Reuters) - Novartis (NOVN.
Gilead to launch generic versions of its hepatitis drugs
Gilead to launch generic versions of its hepatitis drugs
(Reuters) - Gilead Sciences Inc said on Monday it plans to launch generic versions of its hepatitis C drugs in the United States, at a time when regulators are looking to lower healthcare cost...
Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003, Nasal Nalmefene, for Treatment of Opioid Overdose
Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003, Nasal Nalmefene, for Treatment of Opioid Overdose
SANTA MONICA, Calif.
Amicus Therapeutics Acquires Gene Therapy Portfolio of Ten Clinical and Pre-Clinical Stage AAV Programs in Neurologic Lysosomal Storage Disorders
Amicus Therapeutics Acquires Gene Therapy Portfolio of Ten Clinical and Pre-Clinical Stage AAV Programs in Neurologic Lysosomal Storage Disorders
CRANBURY, N.
GTx Announces Top-Line Results from Placebo-Controlled ASTRID Trial of Enobosarm in Women with Stress Urinary Incontinence
GTx Announces Top-Line Results from Placebo-Controlled ASTRID Trial of Enobosarm in Women with Stress Urinary Incontinence
MEMPHIS, Tenn.
With new blood test, Roche dives deeper into personal cancer care
With new blood test, Roche dives deeper into personal cancer care
ZURICH (Reuters) - Swiss drugmaker Roche upped its bet on personalized cancer treatment on Monday, saying it is now ready to sell a blood test around the world that can identify common gene mu...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand